ArticleRisk analysis : an official publication of the Society for Risk Analysis2012
Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models.
Article in Risk analysis : an official publication of the Society for Risk Analysis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it.
- ESR/ERS white paper on lung cancer screening.European radiology · 2015Guideline
- Prediction models and risk assessment for silicosis using a retrospective cohort study among workers exposed to silica in China.Scientific reports · 2015Trial
- Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024Article
- Assessing the efficiency of eligibility criteria for low-dose computed tomography lung screening in China according to current guidelines.BMC medicine · 2024Article
- The Role of Smoking Status in Making Risk-Informed Diagnostic Decisions in the Lung Cancer Pathway: A Qualitative Study of Health Care Professionals and Patients.Medical decision making : an international journal of the Society for Medical Decision Making · 2024Article
- Opportunistic lung cancer screening with low-dose computed tomography in National Cancer Center of China: The first 14 years' experience.Cancer medicine · 2024Article
- Association between a family history of cancer and multiple primary lung cancer risks: a population-based analysis from China.BMC pulmonary medicine · 2023Article
- Irritability and risk of lung cancer: a Mendelian randomization and mediation analysis.Journal of cancer research and clinical oncology · 2023Article
- New insights into the biology and development of lung cancer in never smokers-implications for early detection and treatment.Journal of translational medicine · 2023Review
- Is lung cancer in never smokers still an unknown disease?Translational cancer research · 2022Article
- Association between family history and lung cancer risk among Chinese women in Singapore.Scientific reports · 2021Article
- Anticancer and immunomodulatory effect of rhaponticin on Benzo(a)Pyrene-induced lung carcinogenesis and induction of apoptosis in A549 cells.Saudi journal of biological sciences · 2021Article
- Protective Effects of Thymoquinone, an Active Compound ofMolecules (Basel, Switzerland) · 2021Article
- Gene Expression and In Vitro Pharmacogenetic Studies of Dopamine and Serotonin Gene Receptors in Tuberculosis.Tanaffos · 2021Article
- Indoor radon exposure and excess of lung cancer mortality: the case of Mexico-an ecological study.Environmental geochemistry and health · 2021Article
- Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.Clinical lung cancer · 2020Article
- Lung Cancer Incidence in Nonmetropolitan and Metropolitan Counties - United States, 2007-2016.MMWR. Morbidity and mortality weekly report · 2019Article
- Cancer Progress and Priorities: Lung Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019Review
- Confluent impact of housing and geology on indoor radon concentrations in Atlanta, Georgia, United States.The Science of the total environment · 2019Article
- Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?Journal of global oncology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In this chapter we review the epidemiology of lung cancer incidence and mortality among never smokers/nonsmokers and describe the never smoker lung cancer risk models used by the Cancer Intervention and Surveillance Network (CISNET) modelers. Our review focuses on those influences likely to have measurable population impact on never smoker risk, such as secondhand smoke, even though the individual-level impact may be small. Occupational exposures may also contribute importantly to the population attributable risk of lung cancer. We examine the following risk factors in this chapter: age, environmental tobacco smoke, cooking fumes, ionizing radiation including radon gas, inherited genetic susceptibility, selected occupational exposures, preexisting lung disease, and oncogenic viruses. We also compare the prevalence of never smokers between the three CISNET smoking scenarios and present the corresponding lung cancer mortality estimates among never smokers as predicted by a typical CISNET model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.